NEW RULES FOR ME and maybe some of you. I hope all of you

New Post Public Reply Private Reply Replies (1) Message Board
biomanbaba
NEW RULES FOR ME and maybe some of you. I hope all of you have studied the "Investors lifecycle"so I dont need to teach it. Briefly for those who may not have there are three
main points in the cycle. Early years where you can take enormous risks because
you have a lifetime ahead to recover. Middle years where your earnings from
work are expected to be at a maximum and you have to reduce risk in anticipation of phase 3. Finally phase 3 where you have to be risk averse in order to keep from becoming OLD AND POOR. Old man time has caught up with me and next year
is the first year of my being a Phase 3 person by common defintion. Now I refuse
to be bound by the common wisedom......get some EFTs and Gold and Muni Bonds
and forget the world of individual equities. Market Maven/business school type
individuals like myself are not bound by the common wisedom but we ABSOLUTELY MUST evolve strategies to mitigate risk allowed to Phase 1 & 2 people because
TIME to RECOVER is NOT available to us.
I conducted a review of my recent performance in order to find parameters
that would allow me to mitigate risk while adhering to the strategies I have developed over the last decade. Last year we had Four big winners in the MAG7
...THLD 600% IMUC a Double CTIX 300% and CLSN 400%. Before you start booing and
wanting to write me that CLSN was a loser...recall we took it from 2 to 8 and
then some sat there and watched it crash and others including me only took our basis off. My result was 3 winners and a break even. Others actually lost money.
These outcomes were not satisfactory. What can we learn and how can we improve results? I plowed thru hundreds of trades and situations and charts and found a common theme. WE have a new rule (or at least I do and those who ignore it take responsibility for their own actions)
TAKE HALF AT FOUR AND BUY 2, Then party with 20....the shorthand I will use
to describe this
Never face a binary where the shares are up 400% without taking half off.
Set aside 20% of the take off to have a good time smelling the roses somewhere. Use the remain 80% to create TWO piles for reinvestment.
With the reinvestment funds BUY Two positions. One is your NEXT BEST CATALYST
and the other is your BEST VERY LONG TERM VALUE.
Following this program EVERY time you have an explosive winner you LOCK IN
at least a DOUBLE and DIVERSIFY it. You arent going to die with regrets about
not making progress on your own personal bucket list because of your 20% good time budget.
I plan to do this at least until ALL 14 of the MAG7 and CB7 face the FDA..
then and only then will I condsider retreating to EFTs et al.
Good Luck to ALL
BIOMANBABA
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Operational Investments That Pay Off: From Equipment to Efficiency

Updated Category Investing Views 913

Profit margins don’t grow on paper. They’re built in fields, on job sites, and across every mile a work truck covers. While most investors fixate on markets and financial instruments, the decisions that shape long-term returns often come down to how a business invests in its day-to-day operations. From machinery to mobility, the assets that power a company’s core...

Continue Reading
Capricor Therapeutics Boosts Market Confidence with New Deals

Updated Category News Views 82

Capricor Therapeutics Jump as Oppenheimer Updates Price Target Oppenheimer has recently adjusted its forecast for Capricor Therapeutics (NASDAQ: CAPR), increasing the price target from $14.00 to $15.00, while maintaining an Outperform rating for the stock. This revision follows Capricor's announcement that they have established binding terms for the European...

Continue Reading
Twelve Labs Partners with AWS to Revolutionize Video Search

Updated Category News Views 186

Transforming Video Content into Searchable Data In a significant move for the field of artificial intelligence, Twelve Labs is collaborating with Amazon Web Services (AWS) to enhance the way videos are analyzed and interacted with. This partnership strives to make video content as searchable and accessible as text, an advancement that many experts believe is crucial in...

Continue Reading
Mustang Energy Commences Uranium Exploration at New Project

Updated Category News Views 211

Mustang Energy Begins Exploration at Cluff Lake North Project Mustang Energy Corp. (CNSX: MEC.CN, Other OTC: MECPF, Frankfurt: 92T) has officially started its exploration activities at the Cluff Lake North Project. This project is situated in the renowned Athabasca Basin, a region celebrated for its rich mineral potential. The company has recently secured an option...

Continue Reading
Explore Romantic Getaways: Top Valentine's Day Travel Picks

Updated Category News Views 254

Embrace the Spirit of Romance This Valentine's Day As Valentine's Day approaches, many couples are beginning their journey toward unforgettable experiences rather than just exchanging gifts. This day symbolizes love and connection, inviting everyone to explore the world with their partner. Travel has become the new trend for celebrating this special occasion, with couples...

Continue Reading